Predictive oncology acquires zpredicta, inc.

Zpredicta has developed a patented tumor-specific 3d cell culture platform that is complementary to predictive oncology's artificial intelligence (ai) platform developed by helomics. zpredicta's uniquely designed 3d culture systems create a tumor microenvironment that is closer to the patient's actual tumor than the currently available alternatives. zpredicta has developed a patented tumor-specific 3d cell culture platform that is complementary to predictive oncology's artificial intelligence (ai) platform developed by helomics. zpredicta's uniquely designed 3d culture systems create a tumor microenvironment that is closer to the patient's actual tumor than the currently available alternatives.
POAI Ratings Summary
POAI Quant Ranking